0 results for 'Kirkland %26 Ellis'
How to Grow Fast Like Kirkland
Class actions are set for significant growth across the globe and law firms that corner the market could reap big rewards, writes the Global Lawyer.Kirkland Partner Poised to Launch Paul Weiss UK Funds Practice
The expected hire continues the expansive New York firm's rapid assault on the UK capital, which began late last year.Rebound in Deals or More Cuts? Law Firm Leaders on What to Expect in 2024
2023 wasn't easy, but will 2024 be any better? Law.com International speaks with leaders at Kirkland, Freshfields , Weil, Skadden and Eversheds to get some answers.Senior Partners—Retention, Not Cyber Crime, Is Your Biggest Issue in 2024
Cyber threats are real and dangerous—but good old fashioned retention is number one, and goes to the very heart of your firm's success and survival, writes The Global Lawyer.'Where Others Are Faltering, We're Leaning In': Sidley Austin's Leaders on the Firm's Long Game
Major hires from firms like Paul Weiss put the firm on everyone's radar this year; and potential culture clashes aren't dampening the firm's appetite for expansion and disruption, and not just in private equity.View more book results for the query "Kirkland %26 Ellis"
Paul Weiss' Trio of Kirkland Hires Could Each Score $20M Yearly
Their potential pay may not be the highest for partners at high-end Am Law 25 firms, where annual compensation for a handful is more than $25 million.5 Reasons to Leave Kirkland for Paul Weiss
The impending large transatlantic team defection points to the strategic direction of both firms, writes the Global Lawyer.A&O-Shearman Combo is Just the First Domino in the Merger Rally
The pressure on the likes of Ashurst, Clifford Chance, O'Melveny, Pillsbury and others to also do a deal has suddenly intensified, writes the Global Lawyer.Smaller but Mightier: The 2023 Am Law 200 Outperforms Larger Firms
For the Am Law Second Hundred, 2022 was a great year. They are looking to continue that growth, but is their market-leading performance here to stay?Kirkland and Milbank Advise on €2.4BN European Biopharma Acquisition
In 2020, Kirkland also advised the private equity firms on their initial acquisition of Polyplus, a global supplier of transfection reagents used in cell and gene therapies.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
From Burnout to Breakthrough: How Technology Enhances Legal Wellness
Brought to you by Nuix
Download Now
Top 10 Compliance Concerns for Private Fund Managers
Brought to you by Ontra
Download Now